Resweratrol jako dobroczyńca w profilaktyce chorób układu krążenia

• Authors: Beata Olas

Title variants

EN

Resveratrol as a benefactor in prophylaxis of cardiovascular diseases

• Languages of publication: PL EN

Abstracts

EN

This is an overview of the currently available evidence of antioxidant and antiplatelet properties of resveratrol, a natural phenolic compound present at high concentrations in grapes and red wine. It presents the effects of resveratrol on biochemical processes (eicosanoid synthesis and polyphosphoinositide metabolism) in blood platelets, its interactions with lipid membranes, and the mechanisms involved in its action on blood platelets, the cells which play an important role in pathogenesis of cardiovascular diseases.

• Journal: Kosmos
• Year: 2006
• Volume: 55
• Issue: 2-3
• Pages: 277-285

Dates

published

2006

Contributors

author

Beata Olas

• Katedra Biochemii Ogólnej Uniwersytet Łódzki, Banacha 12/16, 90-237 Łódź, Polska

References

• Bartosz G., Janaszewska A., Ertel D., 1998. Spectrophotometric determination of peroxyl radical trapping capacity. Curr. Topics Biophys. 22, 11-13.
• Bertelli A. A., Giovannini L., Giannessi D. Z., Migliori M., Bernini W., Fregoni M., Bertelli A., 1995. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int. J. Tissue React. 17, 1-3.
• Bertelli A. A., Giovannini L., Bernini W., Migliori M., Fregoni M., Baveresco L., Bertelli A., 1996. Antiplatelet activity of cis-resveratrol. Drugs Exp. Clin. Res. 22, 61-63.
• Blache D., Gesquiere L., Loreau N., Durand P., 1999. Oxidant stress: the role of nutrients in cell-lipoprotein interactions. Proc. Nutrit. Soc. 58, 559-563.
• Bohm M., Rosenkrantz S., Laufs U., 2002. The „French Paradox“. Dtsch. Med. Wochenschr. 127, 2748-2756.
• Cao Y., Wang F., Liu H. Y., Han R., 2005. Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J. Asian. Nat. Prod. Res. 7, 205-213.
• Clement M. V., Hirpara J. L., Chawdhury S. H., Pervaiz S., 1998. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92, 996-1002.
• Daniel O., Meier M. S., Schlatter J., Frischhnecht P., 1999. Selected phenolic compounds in cultivated plants: ecologic functions, health implications, and modulation by pesticides. Environ. Health Perspect. 107, 109-114.
• Das D. K., Sato M., Ray P. S., Engelman R. M., Bertelli A. A., Bertelli A., 1999. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp. Clin. Res. 25, 115-120.
• Dob rydneva Y., Williams R. L., Blackmore P. F., 1999. Trans-resveratrol inhibits calcium influx in thrombin-stimulated human platelets. Br. J. Pharmacol. 128, 149-157.
• Dutta-Roy A. K., 2002. Dietary components and human platelet activity. Platelets 13, 67-75.
• Eiattar T. M. A., Virji A. S., 1999. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anti-Cancer Drugs 10, 187-193.
• Fauconneau B., Waffo Teguto P., Huguet F., Barrier L., Decendit A., Merillon J. M., 1997. Comparative study of radical scavenger and antioxidant properties of phenolic compound from Vitis vinifera cell cultures using in vitro tests. Life Sci. 61, 2103-2110.
• Frankel E. N., Kanner J., German J. B., Parks E., Kinsella J. E., 1993. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341, 454-457.
• Frankel E. N., Waterhouse A. L., Teissedre P. L., 1995. Principal phenolic photochemicals in selected Californis wines and their antioxidant activity in inhibiting oxidation of human low density lipoproteins. J. Agri. Food Chem. 43, 890-894.
• Fremont L., 2000. Biological effects of resveratrol. Life Sci. 66, 663-673.
• Fremont L., Belguendouz L., Delpal S., 1999. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci. 64, 2511-2521.
• Fukuda S., Kaga S., Zhan L., Bagchi D., Das D. K., Bertelli A., Maulik N., 2006. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell. Biochem. Biophys. 44, 43-49.
• Fukuhara K., Miyata N., 1998. Resveratrol as a new type of DNA-cleaving agent. Bioorg. Med. Chem. Lett. 8, 3187-3192.
• Gottrand F., Beghin L., Duhal N., Lacroix B., Bonte J. P., Fruchart J. C., Luc G., 1999. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apoprotein AII. Eur. J. Clin. Invest. 29, 387-394.
• Gu X., Creasy L., Kester A., Zeece M., 1999. Capillary electrophoretic determination of resveratrol in wines. J. Agric. Food Chem. 47, 3223-3227.
• Halliwell B., 2000. Lipid peoroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc. Res. 47, 410-418.
• Halvorsen B. L., Holte K., Myhrstad M. C. W., Barikmo I., Hvattum E., Remberg S. F., Wold A. B., Haff ner K., Baugerod H., Andersen L. F., Moskaug J. O., Jacob s D. R., Blomhoff R., 2002. A sysytemic screening of total antioxidants in dietary plants. J. Nutr. 132, 461-471.
• Hsieh T., Wu J. M., 1999. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell. Res. 249, 109-115.
• Hung L. M., Chen J. K., Huang S. S., Lee R. s., Su M. j., 2000. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47, 549-555.
• Ignatowicz E., Bear-Dubo wska W., 2001. Resveratrol, a natural chemopreventive agent against degenerative diseases. Pol. J. Pharmacol. 53, 557-569.
• Keevil J. G., Osman H. E., Reed J. D., Folts J. D., 2000. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J. Nutr. 130, 53-56.
• Krotz F., Sohn Y. Y., Pohl U., 2004. Reactive oxygen species. Players in the platelet game. Arterioscler. Thromb. Vasc. Biol. 24, 1988-1996.
• Leonard S. S., Xia C., Jiang B. H., Stinefect B., Klandorf H., Harris G. H., Shi X., 2003. Resveratrol scavenges reactive oxygen species and eefects radic-induced cellular responses. Biochem. Biophys. Res. Com. 309, 1017-1026.
• Macheix J. J., Fleuriet A., Billot J., 1990. Fruit phenolics. CRS Press, Boca Raton, Florida.
• Martinez J., Moreno J. J., 2000. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 59, 865-870.
• Mehta J. L., Chen L. Y., Kone B. C., Mehta P., Turner P., 1995. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J. Lab. Clin. Med. 125, 370-377.
• Munday J. S., Thompson K. G., James K. A., Manktelow B. W., 1999. The effect of moderate alcohol consumption as either red or white wine in the C57BL/6 mouse atherosclerosis model. Coron. Artery Dis. 10, 97-102.
• Nowak P., Olas B., Bald E., Glowacki R., Wachowicz B., 2003. Peroxynitrite-induced changes of thiol groups in human blood platelets. Platelets 14, 375-379.
• Olas B., 2003. Antyoksydanty obecne w diecie w walce z miażdżycą. Kosmos 52, 249-258.
• Olas B., Wachowicz B., 2002. Resveratrol and vitamin c as antioxidants in blood platelets. Thromb. Res. 106, 143-148.
• Olas B., Wachowicz B., 2005. Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets, 16, 251-260.
• Olas B., Żbikowska H. M., Wachowicz B., Krajewski T., Buczyński A., Magnuszewska A., 1999. Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim. Polon. 46, 991-996.
• Olas B., Wachowicz B., Saluk-Juszczak J., Zieliński T., Kaca W., Buczyński A., 2001a. Antioxidant activity of resveratrol in endotoxin — stimulated blood platelets. Cell Biol. Toxicol. 17, 117-125.
• Olas B., Wachowicz B., Szewczuk J., Saluk-Juszczak J., Kaca W., 2001b. The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin. Microbios 105, 7-13.
• Olas B., Wachowicz B., Saluk-Juszczak J., Zieliński T., 2002a. Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin. Thromb. Res. 107, 141-145.
• Olas B., Wachowicz B., Stochmal A., Oleszek W., 2002b. Anti-platelet effects of different phenolic compounds from Yucca schidigera Roezl. Bark. Platelets 13, 167-173.
• Olas B., Wachowicz B., Stochmal A., Oleszek W., 2003. Inhibition of oxidative stress in blood platelets by different phenolics from Yucca schidigera Roezl. Bark. Nutrition 19, 633-640.
• Olas B., Nowak P., Wachowicz B., 2004a. Resveratrol protects against peroxynitrite - induced
• thiol oxidation in blood platelets. Cell. Mol. Biol. Lett. 9, 577-587.
• Olas B., Nowak P., Kołodziejczyk J., Wachowicz B., 2004b. The effects of antioxidants on pero xynitrite-induced changes in platelet proteins. Thromb. Res. 113, 399-406.
• Olas B., Wachowicz B., Holmsen H., Fukami M., 2005a. Resveratrol inhibits polyphosphoinositide cycle in activated platelets” BBA-Biomembranes 1714, 125-133.
• Olas B., Wachowicz B., Majsterek I., Błasiak J., 2005b. Resveratrol may reduce oxidative stress induced by platinum compounds in human plasma, blood platelets and lymphocytes. Anti- Cancer Lett. 16, 659-665.
• Olas B., Wachowicz B., Stochmal A., Oleszek W., 2005c. Inhibition of platelet adhesion and secretion by different phenolics from Yucca schidigera Roezl. Bark. Nutrition 21, 199-206.
• Oleszek W., Sitek M., Stochmal A., Piacente S., Pizza C., Cheeke P., 2000. Resveratrol and other phenolics from the bark of Yucca schidigera Roezl. J. Agri. Food Chem. 49, 747-752.
• Pace-Asciak C. R,., Hahn S., Diamandis E. P., Soleas G., Goldberg M., 1995. The red wine phenolics, trans-resveratrol and quercetin block human platelet aggregation and eicosanoids synthesis: implication for protection against coronary heart disease. Clin. Chim. Acta 23, 207-219.
• Pace-Asciak C. R., Rounova O., Hahn S. E., Diamandis E. P., Goldberg D. M., 1996. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta 246, 163-182.
• Padilla E., Ruiz E., Redondo S., Gordillo-Moscoso A., Slowing K., Tejerina T., 2005. Relationship between vasodilation capacity and phenolics content of Spanish wines. Eur. J. Pharmacol. 517, 84-91.
• Paul B., Chereyathmanjiyil A., Masih I., Chapuis L., Benoit A., 1998. Biological control of Botrytis cinerea causing grey mould disease of grapevine and elicitation of stilbene pytoalexin (resveratrol) by a soil bacterium. FEMS Microbiol. Lett. 165, 65-70.
• Pervaiz S., 2003. Resveratrol: from grapevines to mammalian biology. FASEB J. 17, 1975-1985.
• Peters R. J. G., Moo ns A. H. M., 2001. Platelet function and coronary artery disease. Eur. J. Clin. Invest. 31, 3-5.
• Rein D., Paglieroni T. G., Pearson D. A., Wun T., Schmitz H. H., Gosselin R., Keen C. L., 2000. Cocao and wine polyphenols modulate platelet activation and function. J. Nutr. 130, 2120S-2126S.
• Renauld S., De Lorgeril M., 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523-1526.
• Rotondo S., Rotilio D., Cerletti C. H., De Gaetano G., 1996. Red wine, aspirin and platelet function. Thromb. Haemostas. 76, 813-821.
• Ruf J. C., 1999. Wine and polyphenols related to platelet aggregation and atherothrombosis. Drug Exp. Clin. Res. 25, 125-131.
• Shahidi F., Naczk M. 1995. Food phenolics. RECHNOMIC, Lancaster-Basel.
• Signorelli P., Ghidoni R., 2005. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem. 16, 449-466.
• Sobo lev V. S., Cole R. J., 1999. Trans-resveratrol content in commmercial peanuts and peanut products. J. Argic. Food Chem. 47, 1435-1439.
• Soleas G. J., Goldberg D. M., 1999. Analysis of antioxidant wine polyphenols by gas chromatography- mass spectrometry. Meth. Enzymol. 229, 137-151.
• Strzelecka H., Kowalski J., 2000. Encyklopedia zielarstwa i ziołolecznictwa. PWN, Warszawa.
• Tadolini B., Juliano C., Pin L., Franconi F., Cabrini L., 2000. Resveratrol inhibition of lipid peroxidation. Free Rad. Res. 33, 105-114.
• Wang Z., Huang Y., Zou J., Cao K., Xu Y., Wu J. M., 2002. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Inter. J. Mol. Med. 9, 77-79.
• Wilska-Jeszka J., 2001. Struktura i właściwości antyoksydacyjne polifenoli. Materiały Zjazdowe - Konferencja Naukowa „Antyoksydanty w żywności - aspekty technologiczne i zdrowotne” Łódź, 27-36.
• Wilska-Jeszka J., Podsędek A., 2001. Bioflavonoids as natural antioxidants. Wiadomości Chemiczne 55, 987.
• Wu J M., Wang Z. R., Hsieh T. C. H., Bruder J. L., Zou J. G., Huang Y. Z., 2001. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Inter. J. Mol. Med. 8, 3-17.
• Zhou Q., Hellerman G. R., Solomonson L. P., 1995. Nitric oxide release from resting human platelets. Thromb. Res. 77, 87-96.
• Zima T, Albano E, Ingelman-Sundberg M, Arteel G. E., Thiele G. M., Klassen L. W., Sun A. Y., 2005. Modulation of oxidative stress by alcohol. Alcohol Clin. Exp. Res. 29, 1060-1065.
• Żbikowska H. M., Olas B., Wachowicz B., Krajewski T., 1999. Response of blood platelets to resveratrol. Platelets 10, 251-256.
• Żbikowska H. M., Olas B., 2000. Antioxidants with carcinostatic activity (resveratrol, vitamin E and selenium) in modulation of blood platelet adhesion. J. Physiol. Pharmacol. 3, 513-520